Common Contracts
11 similar Severance and Change of Control Agreement contracts by CytomX Therapeutics, Inc., Cyngn Inc.
Severance and Change of Control AgreementSeverance and Change of Control Agreement • March 7th, 2024 • Cyngn Inc. • Services-computer programming services • California
This Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of ________ (the “Effective Date”), by and between Cyngn Inc. (the “Company”), and ______________ (“Employee”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • August 8th, 2023 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • Delaware
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of [ ] (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and [ ] (“Employee”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 7th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2020 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Carlos Campoy (“Employee”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • February 27th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of February 3, 2020 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Alison Hannah, M.D. (“Employee”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • November 7th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of October 14, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Amy Peterson (“Employee”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of February 27, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Sean McCarthy, D. Phil. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of October 3, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Rachel Humphrey, M.D. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of March 23, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Debanjan Ray (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of May 15, 2017 by and between the Company and Employee, as amended (the “Prior Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and W. Michael Kavanaugh, M.D. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of March 23, 2016 by and between the Company and Employee, as amended (the “Prior Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • May 9th, 2019 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 25, 2019 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Lloyd A. Rowland, Jr. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of May 16, 2018 by and between the Company and Employee, as amended (the “Prior Agreement”).
Amended and Restated Severance and Change of Control AgreementSeverance and Change of Control Agreement • March 2nd, 2017 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of October 3, 2016 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Sean McCarthy, D. Phil. (“Employee”) and amends and restates in its entirety that certain Severance and Change of Control Agreement dated as of April 1, 2015 by and between the Company and Employee, as amended (the “Prior Agreement”).
